Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Skip to main content
We gratefully acknowledge support from the Simons Foundation, member institutions, and all contributors. Donate
arXiv logo
Cornell University Logo

Quantitative Biology > Genomics

arXiv:2004.07697 (q-bio)
COVID-19 e-print

Important: e-prints posted on arXiv are not peer-reviewed by arXiv; they should not be relied upon without context to guide clinical practice or health-related behavior and should not be reported in news media as established information without consulting multiple experts in the field.

[Submitted on 16 Apr 2020 (v1), last revised 4 May 2020 (this version, v2)]

Title:Computational Drug Repositioning and Elucidation of Mechanism of Action of Compounds against SARS-CoV-2

Authors:Francesco Napolitano, Gennaro Gambardella, Diego Carrella, Xin Gao, Diego di Bernardo
View PDF
Abstract:The COVID-19 crisis called for rapid reaction from all the fields of biomedical research. Traditional drug development involves time consuming pipelines that conflict with the urgence of identifying effective therapies during a health and economic emergency. Drug repositioning, that is the discovery of new clinical applications for drugs already approved for different therapeutic contexts, could provide an effective shortcut to bring COVID-19 treatments to the bedside in a timely manner. Moreover, computational approaches can help accelerate the process even further. Here we present the application of computational drug repositioning tools based on transcriptomics data to identify drugs that are potentially able to counteract SARS-CoV-2 infection, and also to provide insights on their mode of action. We believe that mucolytics and HDAC inhibitors warrant further investigation. In addition, we found that the DNA Mismatch repair pathway is strongly modulated by drugs with experimental in vitro activity against SARS-CoV-2 infection. Both full results and methods are publicly available.
Subjects: Genomics (q-bio.GN); Molecular Networks (q-bio.MN)
Cite as: arXiv:2004.07697 [q-bio.GN]
  (or arXiv:2004.07697v2 [q-bio.GN] for this version)
  https://doi.org/10.48550/arXiv.2004.07697

Submission history

From: Francesco Napolitano [view email]
[v1] Thu, 16 Apr 2020 15:11:08 UTC (312 KB)
[v2] Mon, 4 May 2020 22:32:51 UTC (233 KB)
Full-text links:

Access Paper:

  • View PDF
  • Other Formats
license icon view license
Current browse context:
q-bio.GN
< prev   |   next >
new | recent | 2020-04
Change to browse by:
q-bio
q-bio.MN

References & Citations

export BibTeX citation

Bookmark

BibSonomy logo Reddit logo

Bibliographic and Citation Tools

Bibliographic Explorer (What is the Explorer?)
Connected Papers (What is Connected Papers?)
Litmaps (What is Litmaps?)
scite Smart Citations (What are Smart Citations?)

Code, Data and Media Associated with this Article

alphaXiv (What is alphaXiv?)
CatalyzeX Code Finder for Papers (What is CatalyzeX?)
DagsHub (What is DagsHub?)
Gotit.pub (What is GotitPub?)
Hugging Face (What is Huggingface?)
Papers with Code (What is Papers with Code?)
ScienceCast (What is ScienceCast?)

Demos

Replicate (What is Replicate?)
Hugging Face Spaces (What is Spaces?)
TXYZ.AI (What is TXYZ.AI?)

Recommenders and Search Tools

Influence Flower (What are Influence Flowers?)
CORE Recommender (What is CORE?)

arXivLabs: experimental projects with community collaborators

arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.

Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.

Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.

Which authors of this paper are endorsers? | Disable MathJax (What is MathJax?)